Peptide Synthesis Market Report 2026

Peptide Synthesis Market Overview

• Peptide Synthesis market size has reached to $6.18 billion in 2025 • Expected to grow to $9.91 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Rising Incidence Of Chronic Diseases Boosts Growth In The Peptide Synthesis Market • Market Trend: Advancing Next-Generation Peptide Synthesizers To Gain A Competitive Edge • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peptide Synthesis Market?

Peptide synthesis refers to the laboratory process of producing peptides, which are compounds that are short chains of amino acids linked together by chemical bonds. These synthesized peptides have various applications in research, drug development, and medical diagnostics to generate precise sequences that mimic epitopes within particular protein domains. The main types of products and services included in peptide synthesis are reagents, equipment, and services. Reagents in peptide synthesis refer to chemical compounds or substances employed in the process of creating peptides, which are short chains of amino acids linked together by peptide bonds. The types of technologies are involved are solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid and recombinant technology, which are used by several end users, including pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs) and contract research organizations (CROs), and academic and research institutes.

What Is The Peptide Synthesis Market Growth Forecast?

The peptide synthesis market size is expected to see rapid growth in the next few years. It will grow to $9.91 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growth of contract manufacturing and research services, adoption of hybrid and recombinant peptide technologies, increasing collaborations between biotech and pharma companies, demand for custom peptide synthesis, advancements in peptide characterization and analytical technologies. Major trends in the forecast period include increasing use of ai for peptide design and optimization, expansion of precision medicine applications using peptides, integration of cloud and big data for peptide research, use of iot-enabled laboratory devices for real-time monitoring, implementation of smart manufacturing in peptide production.

Global Peptide Synthesis Market Segmentation

1) By Product And Service: Reagents, Equipment, Services 2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology 3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes Subsegments: 1) By Reagents: Amino Acids, Coupling Reagents, Protecting Groups, Cleavage Reagents 2) By Equipment: Peptide Synthesizers, Chromatography Systems, Mass Spectrometers 3) By Services: Custom Peptide Synthesis, Peptide Characterization And Analysis, Peptide Modification Services, Consulting And Support Services

What Is The Driver Of The Peptide Synthesis Market?

Growing chronic diseases are expected to propel the growth of the peptide synthesis market going forward. Chronic diseases refer to illnesses or non-communicable diseases (NCDs) that are long-term health conditions that persist over an extended period and often progress gradually. Peptide synthesis can be used for chronic diseases, as some peptides exert anti-inflammatory and antioxidant activity, which could aid in the prevention of chronic diseases, including cardiovascular diseases. Peptides can address the fundamental causes of chronic disease by targeting particular cellular processes and signaling pathways, opening up novel therapeutic and management options. For instance, in June 2025, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that noncommunicable diseases (NCDs) remain the leading cause of death and disability in the world, including in the WHO European Region. Here, 1 in 5 men and 1 in 10 women die before 70 years of age because of NCDs such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. Therefore, the growing number of chronic diseases is driving the growth of the peptide synthesis industry.

Key Players In The Global Peptide Synthesis Market

Major companies operating in the peptide synthesis market are Thermo Fisher Scientific, Merck KGaA, Lonza Group, Kaneka Corporation, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

Global Peptide Synthesis Market Trends and Insights

Major companies operating in the peptide synthesis market are focusing on introducing next-generation peptide synthesizers such as PurePep Sonata+ to gain a competitive edge in the market. PurePep Sonata+ is an advanced peptide synthesizer that offers improved efficiency, speed, and accuracy compared to traditional peptide synthesizers. For instance, in August 2025, Vapourtec Ltd, a UK-based company specializing in flow-chemistry instruments, introduced the Peptide‑Builder, a compact benchtop peptide synthesizer. The Peptide‑Builder extends the capabilities of conventional peptide synthesizers by incorporating Vapourtec’s Variable Bed Flow Reactor technology. This innovative approach enables continuous-flow solid-phase peptide synthesis, providing precise control over reaction conditions and allowing high-throughput synthesis of multiple peptide sequences. The system also integrates automated software for sequence design, optimized coupling/deprotection protocols, and real-time monitoring of resin volume and reaction progress, ensuring accurate and reproducible peptide production across a wide range of sequences and scales.

What Are Latest Mergers And Acquisitions In The Peptide Synthesis Market?

In May 2023, Biosynth International, Inc., a Switzerland-based chemical manufacturing company, acquired Cambridge Research Biochemicals for an undisclosed amount. Through this acquisition, CRB brings an extensive wealth of knowledge to Biosynth's peptide division, encompassing distinguished proficiency in intricate peptide chemistry and the labeling of fluorescent dyes. Cambridge Research Biochemicals is a UK-based company that produces peptides, synthesizers, antibodies, and related products.

Regional Outlook

North America was the largest region in the peptide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peptide Synthesis Market?

The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Peptide Synthesis Market Report 2026?

The peptide synthesis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.